T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

T Cell Deletion in High Antigen Dose Therapy of Autoimmune Encephalomyelitis

Published:1994-02-25 Issue:5150 Volume:263 Page:1139-1143
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Critchfield Jeffrey M.¹,Racke Michael K.²,Zúñiga-Pflücker Juan Carlos¹,Cannella Barbara³,Raine Cedric S.³,Goverman Joan⁴,Lenardo Michael J.¹

Affiliation:

1. Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

2. Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, Bethesda, MD 20892, USA.

3. Division of Neuropathology, Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

4. Department of Molecular Biotechnology, University of Washington School of Medicine, Seattle, WA 98195, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference63 articles.

1. ALVORD, E.C., ENCEPHALITOGEN-INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS - PREVENTION SUPPRESSION AND THERAPY, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 122: 333 (1965).

2. BELL, R.B., DIVERSE T-CELL RECEPTOR V-BETA GENE USAGE IN THE CENTRAL-NERVOUS-SYSTEM IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, JOURNAL OF IMMUNOLOGY 150: 4085 (1993).

3. BEVERLY, B, REVERSAL OF INVITRO T-CELL CLONAL ANERGY BY IL-2 STIMULATION, INTERNATIONAL IMMUNOLOGY 4: 661 (1992).

4. BOEHME, S.A., EUR J IMMUNOL 23: 152 (1903).

5. Boehme, S. A., Leukemia 7 2: 545 (1993).

Cited by 506 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues;Journal of Autoimmunity;2023-11

2. Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes;Frontiers in Cell Death;2023-10-30

3. Mechanisms of antigen-induced reversal of CNS inflammation in experimental demyelinating disease;Science Advances;2023-03-03

4. Therapeutic potential of tolerance-based peptide vaccines in autoimmune diseases;International Immunopharmacology;2023-03

5. Current trends in luminescence-based assessment of apoptosis;RSC Advances;2023